Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.
Shouval D, Lai CL, Chang TT, Cheinquer H, Martin P, Carosi G, Han S, Kaymakoglu S, Tamez R, Yang J, Tenney D, Brett-Smith H. Shouval D, et al. Among authors: brett smith h. J Hepatol. 2009 Feb;50(2):289-95. doi: 10.1016/j.jhep.2008.10.017. Epub 2008 Nov 19. J Hepatol. 2009. PMID: 19070393 Clinical Trial.
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, Han KH, Chao YC, Lee SD, Harris M, Yang J, Colonno R, Brett-Smith H. Gish RG, et al. Among authors: brett smith h. Gastroenterology. 2007 Nov;133(5):1437-44. doi: 10.1053/j.gastro.2007.08.025. Epub 2007 Aug 14. Gastroenterology. 2007. PMID: 17983800 Clinical Trial.
Cytomegalovirus as a primary pulmonary pathogen in AIDS.
Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA. Waxman AB, et al. Among authors: brett smith h. Chest. 1997 Jan;111(1):128-34. doi: 10.1378/chest.111.1.128. Chest. 1997. PMID: 8996006 Free article.
12 results